Patent · US Active

Use of Butyribacter intestini in preventing and/or treating inflammation-related diseases

US11338000B2 · kind B2 · utility

1Cited by

2References

18Claims

0Family size

Assignee

BGI SHENZHEN · CN

Inventors

Yuanqiang Zou · Nanhu, CN
Liang Xiao · Lo Wu, CN
Xiaoping Li · Lo Wu, CN
Jinghong Yu · Lo Wu, CN
Chuan Liu · Lo Wu, CN

Key dates

Filing date	Dec 8, 2017
Grant date	May 24, 2022
Priority date	—
Expiry date	Dec 10, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided is a use of Butyribacter intestini in preventing and/or treating inflammation-related diseases. Specifically, in the present disclosure, it was firstly discovered that Butyribacter intestini has the function of preventing and/or treating inflammation-related diseases (for example, inflammatory bowel disease, such as ulcerative colitis, gastritis, and common enteritis; and rheumatoid arthritis).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.